"We conduct pharmaceutical clinical research trials phases I-IV in gastrointestinal indications. Please contact us if you have any questions or would like to learn about our studies."

During the past decade, Summit Clinical Research, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summit Clinical Research, LLC" #1 sponsor was "Allergan" with 4 trials, followed by "Ellodi Pharmaceuticals, LP" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Intercept Pharmaceuticals" with 2 trials sponsored and "Genfit" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summit Clinical Research, LLC" #1 collaborator was "DSM Nutritional Products, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Summit Clinical Research, LLC" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Colorectal Cancer" (2 trials), "Eosinophilic Esophagitis" (2 trials) and "Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Summit Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Summit Clinical Research, LLC" are "Drug" (12 trials), "Other" (3 trials), "Combination Product" (1 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Relamorelin" (3 trials), "APT-1011" (1 trials), "APT-1011 3 mg HS" (1 trials) and "Blood Sample Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Summit Clinical Research, LLC" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Summit Clinical Research, LLC". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Summit Clinical Research, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Summit Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".